It revealed a decreased risk of LGA in the group of insulin plus metformin (risk ratio [RR] 0.74 [0.62-0.89]); the effect for the other 4 short-term outcomes of interest did not reach statistical significance, including SGA (RR 1.43 [0.98-2.10]).
← all excerpts
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.
1
—
—